Resmed (RMD) Non Operating Investment Income (2021 - 2026)

Resmed (RMD) has 6 years of Non Operating Investment Income data on file, last reported at -$10.1 million in Q1 2026.

• Quarterly Non Operating Investment Income fell 79.39% year-over-year to -$10.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.5 million (up 20.19% YoY) and the FY2025 annual result came in at -$10.3 million, down 154.61% from the prior year.
• Non Operating Investment Income eased to -$10.1 million in Q1 2026, from $306000.0 in the prior quarter.
• In the past five years, Non Operating Investment Income ranged from a high of $13.9 million in Q1 2024 to a low of -$15.5 million in Q2 2024.
• A 5-year average of -$2.0 million and a median of -$1.7 million in 2022 frame the typical range for Non Operating Investment Income.
• Annual changes were most pronounced in 2023 — Non Operating Investment Income jumped 469.91% — and 2024, when it plunged 876.89%.
• Tracing RMD's Non Operating Investment Income over 5 years: stood at $8.4 million in 2022, then plunged by 122.56% to -$1.9 million in 2023, then rose by 23.78% to -$1.4 million in 2024, then jumped by 121.26% to $306000.0 in 2025, then slumped by 3410.46% to -$10.1 million in 2026.
• The last three Non Operating Investment Income figures came in at -$10.1 million (Q1 2026), $306000.0 (Q4 2025), and -$6.2 million (Q3 2025), per Business Quant data.